UPDATED Apr 25, 2024
High return on equity, past performance and sound balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
APGN | CHF219.00 | -0.9% | 12.6% | CHF655.9m | CHF248.50 | PE24.5x | S2.4% | 5.0% | Media | ||
BRKN | CHF99.70 | 1.6% | 4.3% | CHF1.1b | CHF101.00 | PE20.4x | E6.0% | 4.5% | Capital Goods | ||
KARN | CHF244.00 | 1.0% | 25.4% | CHF1.9b | CHF252.74 | PE28.9x | E7.9% | 2.0% | Capital Goods | ||
BCHN | CHF578.00 | -3.8% | 5.5% | CHF2.0b | CHF604.50 | PE25.2x | E12.8% | 2.1% | Capital Goods | ||
IFCN | CHF1,272.00 | 7.4% | 34.7% | CHF3.1b | CHF1,296.45 | PE32.2x | E9.8% | 1.6% | Tech | ||
BEAN | CHF419.60 | 0.1% | -1.9% | CHF5.2b | CHF461.00 | PE37.7x | E6.8% | 2.0% | Capital Goods | ||
ABBN | CHF44.51 | 0.4% | 38.0% | CHF82.3b | CHF41.12 | PE24.8x | E8.0% | 1.9% | Capital Goods | ||
ASCN | CHF7.41 | -1.9% | -14.2% | CHF266.1m | CHF12.17 | PE15.3x | E12.9% | 4.0% | Healthcare | ||
LOGN | CHF72.18 | 0.5% | 41.7% | CHF11.2b | CHF77.68 | PE25.2x | E5.4% | 1.5% | Tech | ||
SUN | CHF109.00 | -1.1% | 47.8% | CHF3.7b | CHF123.80 | PE16.1x | E8.0% | 3.4% | Capital Goods | ||
CFR | CHF129.25 | 0.6% | -13.4% | CHF76.0b | CHF146.09 | PE19.5x | E7.8% | 2.7% | Consumer Durables | ||
SCHN | CHF222.50 | 1.4% | 17.4% | CHF24.2b | CHF232.47 | PE27x | E5.4% | 1.8% | Capital Goods | ||
GAV | CHF300.00 | 1.4% | -7.1% | CHF213.2m | CHF380.00 | PE8x | S1.6% | 4.0% | Capital Goods | ||
CFT | CHF143.50 | 1.4% | 21.8% | CHF1.1b | n/a | PE11.7x | n/a | 3.8% | Diversified Financials | ||
SAHN | CHF496.00 | 1.2% | 73.4% | CHF312.9m | n/a | PE15.6x | n/a | 1.8% | Tech | ||
PNHO | CHF51.60 | 2.4% | -2.6% | CHF298.8m | n/a | PE17.6x | n/a | 4.3% | Capital Goods | ||
OBSN | CHF0.006 | 20.0% | -93.2% | CHF703.1k | n/a | PE0.1x | n/a | n/a | Pharmaceuticals & Biotech |